Glenmark Pharma plans to commence of Desmopressin Acetate tablets immediately.
Glenmark Pharmaceuticals has been granted final approval by the USFDA for Desmopressin Acetate tablets, 0.1 mg and 0.2 mg, the therapeutic equivalent of DDAVP, 0.1 mg and 0.2 mg, of Ferring Pharmaceuticals.
Glenmark plans to commence of Desmopressin Acetate tablets immediately.
Glenmark Pharmaceuticals has been granted final approval by the USFDA for Desmopressin Acetate tablets, 0.1 mg and 0.2 mg, the therapeutic equivalent of DDAVP, 0.1 mg and 0.2 mg, of Ferring Pharmaceuticals.
Glenmark plans to commence of Desmopressin Acetate tablets immediately.
No comments:
Post a Comment